732
Views
5
CrossRef citations to date
0
Altmetric
Research Article

Evaluation of tolerance and toxicity of high-dose-rate brachytherapy boost combined with interstitial hyperthermia for prostate cancer

, &
Pages 324-330 | Received 03 Nov 2014, Accepted 10 Dec 2015, Published online: 07 Apr 2016

Figures & data

Table 1. Patient characteristics.

Table 2. Criteria for acceptance of HDRBT treatment plans.

Table 3. Hyperthermia (IHT) parameters.

Table 4. Dose–volume histogram parameters of HDRBT.

Table 5. Acute complications of HDRBT boost combined with IHT (N = 76). Median follow-up time 26.3 months.

Table 6. Procedure-related adverse events.

Table 7. Late toxicities of HDRBT combined with IHT (N = 59). Median follow-up time 29.7 months (range 18.4–43.0).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.